Bio Business

» biobusiness, FDA, tuberculosis and biotech

Most Recent

image: Flux and Uncertainty in the CRISPR Patent Landscape

Flux and Uncertainty in the CRISPR Patent Landscape

By Aggie Mika | October 1, 2017

The battle for the control of the intellectual property surrounding CRISPR-Cas9 is as storied and nuanced as the technology itself.


image: Accessing Drugs for Medical Aid-in-Dying

Accessing Drugs for Medical Aid-in-Dying

By Catherine Offord | August 17, 2017

A fraught market for the barbiturates prescribed to terminally ill patients who choose to end their lives has physicians turning to options outside big pharma.


image: Learning from Iceland’s Model for Genetic Research

Learning from Iceland’s Model for Genetic Research

By Catherine Offord | June 1, 2017

The Scandinavian island’s unique combination of genetic homogeneity, genealogical tradition, and high participation in research make it a prime location for discovery and validation of drug targets.

1 Comment

image: Oligonucleotide Therapeutics Near Approval

Oligonucleotide Therapeutics Near Approval

By Catherine Offord | December 1, 2016

Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.


image: The Growth of Iowa Biotech

The Growth of Iowa Biotech

By Jenny Rood | August 1, 2016

The state’s industry draws inspiration from medicine as well as agriculture.

1 Comment

image: Picking Up the Pace

Picking Up the Pace

By Kate Yandell | January 1, 2016

FDA designations promise to expedite the approval of drugs for conditions ranging from infectious disease to cancer.


image: Battling the Bulge

Battling the Bulge

By Bob Grant | November 1, 2015

Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.


image: The Sounds of Silence

The Sounds of Silence

By Jenny Rood | September 1, 2015

Science-based tinnitus therapeutics are finally coming into their own.


image: Lazarus Drugs

Lazarus Drugs

By Kate Yandell | February 1, 2015

While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.  

1 Comment

image: Cannabis Biotech

Cannabis Biotech

By Daniel Cossins | December 1, 2014

As medical marijuana businesses set up shop across the U.S., a handful of companies are taking the pharmaceutical route, guiding cannabis-derived drugs through clinical trials.


Popular Now

  1. Could Rapamycin Help Humans Live Longer?
  2. Renowned Physicist Stephen Hawking Dies
  3. Elena Rybak-Akimova, Chemical Kinetics Expert, Dies
  4. University of Oregon Erecting a $1-Billion Science Center